BioSpace News Archive

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has received notice from Bank of America that its application for a Paycheck Protection Program loan (a “PPP Loan”) under the CARES Act has been approved.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PROLIFT Lateral Fixated System.

Nascent Biotech, Inc., (OTCQB: NBIO), a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment of cancer, today announced that it will be presenting at the Planet MicroCap Showcase 2020 on Wednesday, April 22 at 7:00 AM EST.

CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the production and global distribution of CentoSwab™.

Shinkowa Pharmaceutical Co., Ltd. (Head Office: Tokyo Chuo-Ward, CEO: Megumi Tanaka) is the largest nutraceutical (health supplemental food which is scientifically proved) producer of β-nicotinamide mononucleotide (NMN) blended nutraceutical, which is effective to maintain health and longevity, providing high-purity NMN to universities and researchers both domestic and foreign.

POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today provided a corporate update and announced its cash position and revenue for the first quarter ended March 31, 2020.

MOBILion Systems, Inc. is partnering with Drs. Lance Wells and Michael Tiemeyer, pioneering researchers at the Complex Carbohydrate Research Center, University of Georgia, to conduct COVID-19 glycan analysis using the company’s patented SLIM separations technology..

Progentec, a leader in next-gen diagnostics and digital technologies for the management of autoimmune diseases, is announcing the launch of the OASIS Study.

Healthcare Trust of America, Inc. (NYSE: HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that on Tuesday, May 5, 2020, after the market closes, HTA will report its financial results for the three months ending March 31, 2020.

SpendEdge, a leading procurement market intelligence company, has announced the completion of its article that reveals the top 5 coronavirus risk assessment strategies that have proven functional in mitigating the emerging healthcare industry supply chain challenges.